Upgrade to SI Premium - Free Trial

BMO Capital Reiterates Market Perform Rating on Novo Nordisk (NVO)

September 29, 2026 9:35 AM
BMO Capital analyst Evan Seigerman reiterated a Market Perform rating and $47.00 price target on Novo Nordisk (NYSE: NVO).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments